Table 1.
Patients. Data from SCA2 patients, SCA3 patients and control individuals involved in this study. List of patient number, age at death, gender, diagnosis and CAG repeats, if available. Control patients were without history of neurodegenerative or psychiatric diseases. n.d.: not determined.
| Patient number | Age at death | Gender | Diagnosis | CAG‐repeats |
|---|---|---|---|---|
| 1 | 26 | F | SCA2 | 52/n.d. |
| 2 | 51 | M | SCA2 | 39/20 |
| 3 | 52 | M | SCA2 | 35/33 |
| 4 | 55 | M | SCA2 | 40/22 |
| 5 | 88 | F | SCA2 | 36/22 |
| 6 | 45 | M | SCA3 | 69/n.d. |
| 7 | 52 | M | SCA3 | 69/14 |
| 8 | 62 | F | SCA3 | 75/20 |
| 9 | 63 | M | SCA3 | n.d. |
| 10 | 73 | M | SCA3 | 65/28 |
| 11 | 85 | M | SCA3 | 66/21 |
| 12 | 52 | F | Control | n.d. |
| 13 | 59 | M | Control | n.d. |
| 14 | 62 | F | Control | n.d. |
| 15 | 84 | M | Control | n.d. |